advertisement
11.4 Prostaglandins (22)
Showing records 1 to 22
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins22621 Effect of latanoprost and timolol on the histopathology of the human conjunctiva
Terai N; Schlötzer-Schrehardt U; Lampel J; Böhm AG; Rummelt C; Schmidt E; Pillunat LE
British Journal of Ophthalmology 2009; 93: 219-224
23044 Endogenous bioactive lipids and the regulation of conventional outflow facility
Wan Z; Woodward DF; Stamer WD
Expert Review of Ophthalmology 2008; 3: 457-470
23359 Bimatoprost-induced calcium signaling in human T-cells does not involve prostanoid FP or TP receptors
Chen J; Lu RT; Lai R; Dinh T; Paul D; Venadas S; Wheeler LA
Current Eye Research 2009; 34: 184-195
22778 Study on the influence of the treatment with some newly synthesized antiglaucoma prostamides on the hematological parameters on rats
Udeanu DI; Mihele D; Cocu F; Caraene G; Vulturescu V; Iova D
Farmacia 2008; 56: 669-674
22730 Effect of travoprost on intraocular pressure during 12 months of treatment for normal-tension glaucoma
Suh MH; Park KH; Kim DM
Japanese Journal of Ophthalmology 2009; 53: 18-23
22679 Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy
Liu JH; Medeiros FA; Slight JR; Weinreb RN
Ophthalmology 2009; 116: 449-454
22970 Performing meta-analysis with incomplete statistical information in clinical trials
Ma J; Liu W; Hunter A; Zhang W
BMC medical research methodology 2008; 8: 56
22850 Changes in intraocular pressure following a switch from latanoprost monotherapy to latanoprost/timolol fixed combination therapy in patients with primary open-angle glaucoma or ocular hypertension: Results from a clinical practice database
Lazaridou M-N; Montgomery DI; Ho WO; Jaberoo D
Current Medical Research and Opinion 2008; 24: 2725-2728
23397 Immunohistochemical expression of HLA-DR in the conjunctiva of patients under topical prostaglandin analogs treatment
Rodrigues Mde L; Felipe Crosta DP; Soares CP; Deghaide NH; Duarte R; Sakamoto FS; Furtado JM; Paula JS; Donadi EA; Soares EG
Journal of Glaucoma 2009; 18: 197-200
22977 Prostanoids for the management of glaucoma
Arranz-Marquez E; Teus MA
Expert Opinion on Drug Safety 2008; 7: 801-808
23043 Reporting of noninferiority and equivalence randomized trials for major prostaglandins: A systematic survey of the ophthalmology literature
Eyawo O; Lee C-W; Rachlis B; Mills EJ
Trials 2008; 9: 69
22612 Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials
Honrubia F; García-Sánchez J; Polo V; de la Casa JM; Soto J
British Journal of Ophthalmology 2009; 93: 316-321
22641 Increased iridial pigmentation in Chinese eyes after use of travoprost 0.004%
Huang P; Zhong Z; Wu L; Liu W
Journal of Glaucoma 2009; 18: 153-156
22530 The effect of latanoprost on ocular blood flow
Harris A; Garzozi HJ; McCranor L; Rechtman E; Yung CW; Siesky B
International Ophthalmology 2009; 29: 19-26
22876 Comparison of twice-daily and three-times-daily dosing of dorzolamide in ocular hypertension and primary open-angle glaucoma patients treated with latanoprost
Lupinacci APC; Netland PA; Fung KH; Evans D; Zhao Y
Advances in Therapy 2008; 25: 231-239
22981 Additive effect of dorzolamide hydrochloride to patients taking travoprost: A retrospective study
Boyer S; Gay D
Optometry 2008; 79: 501-504
22523 Adjunctive use of tafluprost with timolol provides additive effects for reduction of intraocular pressure in patients with glaucoma
Egorov E; Ropo A; on behalf of the Investigators
European Journal of Ophthalmology 2009; 19: 214-222
22676 Corneal penetration into rabbit aqueous humor is comparable between preserved and preservative-free tafluprost
Pellinen P; Lokkila J
Ophthalmic Research 2009; 1: 118-122
22663 Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study
Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
Ophthalmology 2009; 116: 191-199
22502 Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model
Stewart WC; Stewart JA; Mychaskiw MA
Eye 2009; 23: 132-140
22944 Cost effectiveness of travoprost versus a fixed combination of latanoprost/timolol in patients with ocular hypertension or glaucoma: Analysis based on the UK general practitioner research database
De Natale R; Lafuma A; Berdeaux G
Clinical Drug Investigation 2009; 29: 111-120
22875 A multicentre evaluation of the effect of patient education on acceptance of hyperaemia associated with bimatoprost therapy for glaucoma or ocular hypertension
Trattler W; Noecker RJ; Earl ML
Advances in Therapy 2008; 25: 179-189
